Amy L. Burroughs, Chief Executive Officer at Terns Pharmaceuticals, Inc. (TERN), sold 29,166 shares at $38.07 ($1.1M) on 2026-02-17, disclosed to the SEC on 2026-02-18.
Open-market sale of $1.1M TERN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.07 | 2,341 | $89K | 7.8% |
| 2 | $38.07 | 2,341 | $89K | 7.8% |
| 3 | $39.22 | 8,159 | $320K | 28.0% |
| 4 | $39.22 | 8,159 | $320K | 28.0% |
| 5 | $39.80 | 4,083 | $163K | 14.2% |
| 6 | $39.80 | 4,083 |
| $163K |
| 14.2% |
| Total | $39.20 avg | 29,166 | $1.1M | 100% |
| Filing → |
| TERN | SELL | 2026-01-06 | $5.4M | — | Filing → |
| TERN | BUY | 2025-06-25 | $180K | — | Filing → |
| TERN | BUY | 2025-02-03 | $3K | — | Filing → |